An antibody being developed by AstraZeneca for the treatment of light chain (AL) amyloidosis has failed to move the needle in ...

Healthinote is a smartphone-based toolkit designed to boost patient engagement by providing personalised, trustworthy, and ...

Hong Kong-based Sino Biopharm, which took its stake in LaNova when it participated in the company's $42 million financing ...

"Given the Supreme Court's ruling, HHS is now permitted to move forward with a portion of its RIF. Accordingly, you are ...

Sanofi has been granted a speedy review from the FDA for a gene therapy for geographic atrophy (GA), a complication of age-related macular degeneration (AMD), as it prepares to test it in a clinical ...

A series of adverts for weight-loss services have been banned by the Advertising Standards Authority in the UK for promoting ...

The readout is particularly welcome for AZ as baxdrostat (formerly CIN-107) showed mixed results in earlier hypertension ...

Looking back over the past five years, it's clear that healthcare professionals (HCPs) have faced incredible pressure and ...

The US regulator has cleared use of Kerendia (finerenone) for the treatment of heart failure patients who have a left ...

When we think about treating bipolar I disorder (BD-I), the conversation often starts with pharmacotherapy as medication ...

The alliance brings together Cellular Origins, a company focusing on applying robotics and other forms of automation to CGT ...

Hengrui has reported topline data from the 301 study of their dual GLP-1 and GIP agonist HRS9531, administered as a ...